Compile Data Set for Download or QSAR
maximum 50k data
Found 27 Enz. Inhib. hit(s) with all data for entry = 7201
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181020(US9133183, Example 29)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181019(US9133183, Example 15)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181027(US9133183, Example 90)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181018(US9133183, Example 1)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181034(US9133183, Example 91)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181037(US9133183, Example 42)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181035(US9133183, Example 101)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181023(US9133183, Compound A)
Affinity DataIC50:  13nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181026(US9133183, Example 18)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181023(US9133183, Compound A)
Affinity DataIC50:  196nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181019(US9133183, Example 15)
Affinity DataIC50:  370nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181019(US9133183, Example 15)
Affinity DataIC50:  670nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181020(US9133183, Example 29)
Affinity DataIC50:  898nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181023(US9133183, Compound A)
Affinity DataIC50:  990nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181035(US9133183, Example 101)
Affinity DataIC50: >3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181027(US9133183, Example 90)
Affinity DataIC50:  3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181020(US9133183, Example 29)
Affinity DataIC50: >3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181026(US9133183, Example 18)
Affinity DataIC50: >3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181034(US9133183, Example 91)
Affinity DataIC50: >3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181018(US9133183, Example 1)
Affinity DataIC50: >3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181035(US9133183, Example 101)
Affinity DataIC50:  4.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181018(US9133183, Example 1)
Affinity DataIC50: >5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181034(US9133183, Example 91)
Affinity DataIC50: >5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181027(US9133183, Example 90)
Affinity DataIC50: >5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181037(US9133183, Example 42)
Affinity DataIC50: >5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181026(US9133183, Example 18)
Affinity DataIC50: >5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181037(US9133183, Example 42)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In DepthDetails US Patent